Wow a rebuttal of sorts. Thanks Zzatt!!!
So they have already built a gmp faculty. They have the ability to make these bioreactors. How hard would it be to even build a brand new facility. Not overly expensive either.
Now even if making a dose costs $700 to manufacture the old way. (Just using an easy figure). I seem to recall their cog's for Pluristem was 1/7th the cost of traditional methods. So if you could do it for $100 bucks, sell it for $700 bucks, thereby eliminating the competition. Just seems logical to me. To license that out, seems absurd. And I would think that having 2 CEO's that were gifted huge bonuses and have a good salary, would have a much easier time figuring this sort of stuff out than this backseat Joe Schmo.
So you say use my imagination. Please share your thoughts on this. It's pretty easy to throw that out there without letting me have a chance to critique your ideas. I have no problem sharing my thoughts for you to hack apart, so feel free to return the favour.
But I did do some imagining like you asked, and could only come up with one possible way. That would be to get a massive chunk of upfront coin and I'm not talking $50 mil. And of course a sweet royalty off of it. They want to go it alone in their trials then they need a lot of cash and they will reap the rewards if proven successful. But even with that, I still can't justify giving that up when the company could become a manufacturing juggernaut.
I'm sorry if I rub some people the wrong way. I seriously look at all angles both good and bad. All anyone seems to post here are any positive things. I look for someone to give contradictory ideas and thoughts, but rarely get anything back except names. That's exactly what Allo did right after I posted, so I edited my post to include LMAO. And I will take the contagious remark as a compliment. Blue is one of the few that also look at both sides.
He did, after all, coin my favourite line. Hopefully the technology overcomes management. Amen to that. And with the recent run up of we have had, seems like we may be on our way. Love the product but management is suspect. But yes, all will be forgiven if they get something significant done by the end of this year.
GLTA longs
